latin american symposium future perspectives in pulmonary hypertension
TRANSCRIPT
![Page 1: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/1.jpg)
Latin American Symposium
Future Perspectives in Pulmonary Hypertension
![Page 2: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/2.jpg)
Program
• State of the art conferences
• Debates
• Controversies
• Future perspectives
• Quiz & Interactive sessions
![Page 3: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/3.jpg)
State of the Art Conferences
• Management of PH: Current status
• Advances in the treatment: Riociguat
• Clinical studies: PATENT & LEPHT
• CTEPH: Riociguat development
![Page 4: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/4.jpg)
Future Perspectives
• Session II: PH management in Latin America• Current situation• Research in Latin America• Multidisciplinary approach• Patient perspective
• Session III: CTEPH• From diagnosis to treatment (interactive)
![Page 5: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/5.jpg)
Debate I: Left Ventricle
![Page 6: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/6.jpg)
Debate II: COPD
![Page 7: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/7.jpg)
Debate II: COPD
![Page 8: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/8.jpg)
Debate III: Eisenmenger
![Page 9: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/9.jpg)
Controversies in PAH
• 1. Pregnancy
• 2. Instable PH (acute state)
• 3. Combined treatment: sequential vs. upfront
• 4. Best imaging method to study the RV
![Page 10: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/10.jpg)
Controversies
• PH management decisions
• Good decisions
• Informed
• Supported by best evidence
• Compatible with patients values
• Considers patients preferences
• Weigh pros and cons
• Practical
• Poor decisions
• Objective data inadequate
• Too few options considered
• Alternatives unclear
• Values and preferences unexplored
• Roles unclear
• Communication is poor
![Page 11: Latin American Symposium Future Perspectives in Pulmonary Hypertension](https://reader036.vdocuments.site/reader036/viewer/2022082506/5697c01e1a28abf838cd15c5/html5/thumbnails/11.jpg)
Simposio Latinoamericano Perspectivas Futuras en Hipertensión Pulmonar